Susquehanna Fundamental Investments’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $966K | Sell |
279,212
-76,953
| -22% | -$266K | 0.03% | 452 |
|
|
2025
Q1 | $933K | Buy |
356,165
+9,877
| +3% | +$25.9K | 0.01% | 705 |
|
|
2024
Q4 | $1.43M | Buy |
+346,288
| New | +$1.43M | 0.02% | 618 |
|
|
2024
Q2 | $348K | Buy |
53,442
+38,117
| +249% | +$249K | 0.01% | 760 |
|
|
2024
Q1 | $127K | Buy |
+15,325
| New | +$127K | 0.01% | 644 |
|
|
2022
Q4 | – | Sell |
-12,401
| Closed | -$277K | – | 1437 |
|
|
2022
Q3 | $277K | Buy |
+12,401
| New | +$277K | ﹤0.01% | 1180 |
|
|
2022
Q1 | $211K | Buy |
+7,051
| New | +$211K | ﹤0.01% | 1352 |
|
|
2021
Q4 | – | Sell |
-7,300
| Closed | -$230K | – | 1717 |
|
|
2021
Q3 | $230K | Buy |
+7,300
| New | +$230K | ﹤0.01% | 1494 |
|
|
2021
Q2 | – | Sell |
-11,548
| Closed | -$399K | – | 1759 |
|
|
2021
Q1 | $399K | Sell |
11,548
-20,322
| -64% | -$702K | 0.01% | 1217 |
|
|
2020
Q4 | $1.33M | Sell |
31,870
-7,037
| -18% | -$293K | 0.02% | 759 |
|
|
2020
Q3 | $1.66M | Buy |
+38,907
| New | +$1.66M | 0.05% | 492 |
|